Author Archives: Lu Rahman

#Biopharmaceuticals #Covid-19 #Therapeutics

RedHill Biopharma: first patient dosed in US Phase II/III COVID-19 RHB-107 study

RedHill Biopharma, a specialty biopharmaceutical company, has announced that the first patient was dosed in its US Phase II/III study of orally-administered RHB-107 (upamostat)[i], an investigational new drug for patients with symptomatic COVID-19 who do not require hospital care. Dror Ben-Asher, RedHill’s CEO said: “RedHill is rapidly advancing two Phase… Read More

#Covid-19 #News

#Clinical trials #CRO #Drug development

New partnership uses data to help drug developers with patient recruitment

Cerba Research, a healthcare diagnostic company, has formed a partnership with Biokortex, provider of digital solutions to the healthcare sector. This partnership will leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity. “Cerba Healthcare and Cerba Research are committed to investing… Read More

#Editor's Choice #News

#Biotherapeutics #Cancer research #Clinical Trial Authorisation

Avacta announces Phase I Clinical Trial Authorisation (CTA) for AVA6000

Avacta, the developer of Affimer biotherapeutics and reagents, has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for its Clinical Trial Authorisation (CTA) in the UK for a Phase I study of its lead pre|CISION pro-drug, AVA6000 pro-doxorubicin. In AVA6000, doxorubicin has been modified with Avacta’s pre|CISION… Read More

#Cancer Research #News

#Biotechnology #Drug targets

Salipro Biotech patent for direct extraction of membrane proteins and library generation

Swedish biotech company Salipro Biotech has announced that the European Patent Office has issued the European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMXTM) from cells or crude membranes to enable drug… Read More

#Editor's Choice #News

#Clinical trials #Covid-19 #Human trials #Immunology / Virology & Vaccines

World’s first coronavirus Human Challenge study receives ethics approval

The UK will be the first country in the world to run a COVID-19 human challenge study, following approval from the UK’s clinical trials ethics body. Backed by a £33.6 million UK government investment, the first-of-its-kind study for this virus will involve establishing the smallest amount of virus needed to… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Automation / robotics #Biotechnology #Life sciences

SPT Labtech acquires BioMicroLab

SPT Labtech, a global player in the design and development of automated instrumentation and consumables for life science applications, has acquired BioMicroLab, a robotics automation provider for life science laboratories. Headquartered in Northern California, BioMicroLab designs and manufactures laboratory automation equipment for biotechnology and scientific research. BioMicroLab’s extensive range of… Read More

#Editor's Choice #News

#Biotechnology #CRISPR #Genomics #Pharmaceutical #Zebrafish

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio. ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier. ZeClinics is a contract research organisation using zebrafish to carry out services… Read More

#News

#Covid-19 #Diagnostics #Drug development

BioIVT unveils COVID-19 panel to boost vaccine-generated immune response research

BioIVT, provider of research models and services for drug and diagnostic development, has introduced its COVID-19 Vaccination Panel, composed of pre- and post-vaccination serum or PBMC samples, to enable researchers to study blood donors’ vaccine-generated immune response. BioIVT has been providing more than 300 clients with biospecimens to support the… Read More

#Covid-19 #Editor's Choice #News

#Analysis #Liquid chromatography

Waters aims to redefine lab science with new liquid chromatography solution

Waters Corporation has released the Acquity Premier liquid chromatography solution featuring its MaxPeak High Performance Surface (HPS) technology. The solution leverages HPS to vastly improve analytical data quality and eliminate the need for time-consuming and costly passivation, says Waters. Acquity Premier is designed to alleviate the problem of analyte/metal surface… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug discovery #Pharmaceuticals #Rare disease #Therapeutics

The move towards patient-powered, data-driven rare disease drug discovery

By Rayne Rodgers, Vice President and Executive Director of MOVR for Muscular Dystrophy Association (MDA), and Sharon Hesterlee MDA’s Executive Vice President and Chief Research Officer. As an umbrella organisation representing those living with more than 40 types of neuromuscular disorders, the Muscular Dystrophy Association (MDA) contributes significantly to innovations… Read More

#Editor's Choice #Exclusive Content #News

#CDMO #Drug development

Quotient Sciences acquires Arcinova, a UK CDMO

Quotient Sciences, the drug development and manufacturing accelerator, has acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide. The acquisition expands Quotient’s… Read More

#News

#Clinical trials #Life sciences

eClinical Solutions reaches milestone with clinical data platform

eClinical Solutions, a global provider of cloud-based enterprise software and software-driven clinical data services, has revealed a more than 40% annual license growth of its elluminate Clinical Data Platform in 2020. This brings the total global adoption of elluminate to over 100 life sciences companies. elluminate helps life sciences companies… Read More

#News

#Biologics #Cancer immunotherapy #Oncology

Samsung Biologics obtains cancer immunotherapy IND approval from FDA

Samsung Biologics has obtained Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy. In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in Korea, approached Samsung Biologics for the development of EU101(NOV1801), an anti-4-1BB therapeutic monoclonal… Read More

#Cancer Research #News

#Pharmaceuticals

Pfizer head set for ABPI President role

The Association of the British Pharmaceutical Industry (ABPI) has announced that Ben Osborn, UK Country Manager, Pfizer, has been elected as as President-elect of the ABPI. Osborn has over twenty years of experience across a range of leadership roles at Pfizer, where he began his career in 1998. Prior to… Read More

#News

#Drug discovery

New method for asymmetric N,N-acetal synthesis could advance drug development

Scientists identify new method of preparing N,N-acetals with high enantiopurity using diketones, crowning a new approach to synthesising bioactive drugs. Chiral N,N-acetals are an important component of several bioactive drugs and medicines. Owing to this, chemical reactions that lead to high-purity yield of the desired ‘enantiomeric’ form are highly sought… Read More

#Exclusive Content #News